These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35610770)

  • 1. Risk Reduction Is in the Nature of Pharmacists.
    Alderman C
    Sr Care Pharm; 2022 Jun; 37(6):211-212. PubMed ID: 35610770
    [No Abstract]   [Full Text] [Related]  

  • 2. Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.
    Hindi AMK; Jacobs S; Schafheutle EI
    Health Soc Care Community; 2019 May; 27(3):565-598. PubMed ID: 30047617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of community pharmacists on conscientious objection to provide pharmacy services: A theory informed qualitative study.
    Gülpınar G; Keleş Ş; Yalım NY
    J Am Pharm Assoc (2003); 2021; 61(4):373-381.e1. PubMed ID: 33895101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of community pharmacists performing depression screening services.
    O'Reilly CL; Wong E; Chen TF
    Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of community pharmacists in Pakistan about practice change and implementation of extended pharmacy services: a mixed method study.
    Hashmi F; Hassali MA; Saleem F; Saeed H; Islam M; Malik UR; Atif N; Babar ZU
    Int J Clin Pharm; 2021 Aug; 43(4):1090-1100. PubMed ID: 33411180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nature of community pharmacy in home care].
    Onda M
    Nihon Ronen Igakkai Zasshi; 2002 Nov; 39(6):618-25. PubMed ID: 12518413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study of Pharmacists' Attitudes towards and Expectations for Remuneration of Valueadded Pharmacy Services (VAPS) in Bulgaria.
    Balkanski SV; Simeonova JI; Gueorguiev SR; Petkova-Gueorguieva ES; Gitev IG; Getov IN
    Folia Med (Plovdiv); 2020 Jun; 62(2):324-330. PubMed ID: 32666769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Publics' Perceptions of Community Pharmacists and Satisfaction with Pharmacy Services in Al-Madinah City, Saudi Arabia: A Cross Sectional Study.
    El-Kholy AA; Abdelaal K; Alqhtani H; Abdel-Wahab BA; Abdel-Latif MMM
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334609
    [No Abstract]   [Full Text] [Related]  

  • 12. What free services do pharmacists offer? Investigating the provision of unfunded pharmacy services in community pharmacies.
    Abdul Aziz YH; Heydon SJ; Duffull SB; Marra CA
    Res Social Adm Pharm; 2021 Mar; 17(3):588-594. PubMed ID: 32461164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing traditional activities and cognitive pharmaceutical services by community pharmacists: a work sampling study.
    van de Pol J; Koster E; Hövels A; Bouvy M
    Int J Clin Pharm; 2019 Aug; 41(4):872-879. PubMed ID: 31140160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention research to enhance community pharmacists' cognitive services: a systematic review.
    Patwardhan PD; Amin ME; Chewning BA
    Res Social Adm Pharm; 2014; 10(3):475-93. PubMed ID: 24071523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy in transition: A work sampling study of community pharmacists using smartphone technology.
    van de Pol JM; Geljon JG; Belitser SV; Frederix GWJ; Hövels AM; Bouvy ML
    Res Social Adm Pharm; 2019 Jan; 15(1):70-76. PubMed ID: 29550281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives and perceived barriers to pharmacist-prescribed tobacco cessation services in the community pharmacy setting.
    Xiong S; Willis R; Lalama J; Farinha T; Hamper J
    J Am Pharm Assoc (2003); 2021; 61(4S):S39-S48. PubMed ID: 33483273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.